These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23772503)

  • 21. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
    Broedl UC; Lehrke M; Parhofer KG
    MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054
    [No Abstract]   [Full Text] [Related]  

  • 22. Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen.
    Zhang J; Rocha NA; McCullough PA
    Rev Cardiovasc Med; 2018 Mar; 19(1):13-19. PubMed ID: 31032598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
    Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
    Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox.
    González-Gay MA; González-Juanatey C
    Ann Rheum Dis; 2014 Jul; 73(7):1281-3. PubMed ID: 24907362
    [No Abstract]   [Full Text] [Related]  

  • 25. Future perspectives of the pharmacological management of diabetic dyslipidemia.
    Patti AM; Giglio RV; Papanas N; Rizzo M; Rizvi AA
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):129-143. PubMed ID: 30644763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case report of a diabetic woman with very low HDL cholesterol.
    Chaychi L; Kinlaw WB; Asztalos BF; Schaefer EJ
    J Clin Lipidol; 2010; 4(2):133-5. PubMed ID: 21122641
    [No Abstract]   [Full Text] [Related]  

  • 27. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction.
    Haberka M; Okopień B; Gąsior Z
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):123-33. PubMed ID: 26830392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipid management--treatment goal and strategy].
    Koshiyama H
    Nihon Rinsho; 2006 Nov; 64(11):2102-6. PubMed ID: 17087303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease].
    Takamura T
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):836-44. PubMed ID: 23772495
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M
    Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unending saga of fighting cholesterol: Evacetrapib is another fallen warrior.
    Simko V
    Bratisl Lek Listy; 2016; 117(11):625-627. PubMed ID: 28125886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dyslipidemia and atherosclerosis].
    Koba S; Hirano T
    Nihon Rinsho; 2011 Jan; 69(1):138-43. PubMed ID: 21226274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?
    Li N; Fu J; Koonen DP; Kuivenhoven JA; Snieder H; Hofker MH
    Atherosclerosis; 2014 Mar; 233(1):130-8. PubMed ID: 24529133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specific features of cardiovascular diseases and their treatment in women].
    Tereshenko SN; Uskach TM; Kositzina IV; Dzhaiani NA
    Kardiologiia; 2005; 45(1):98-104. PubMed ID: 15699948
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 5. Rheumatic diseases--diagnosis and treatments].
    Mimura T
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):862-8. PubMed ID: 23772499
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dyslipidemia in diabetes mellitus: diagnosis and treatment].
    Oikawa S
    Nihon Rinsho; 2015 Dec; 73(12):2079-83. PubMed ID: 26666156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low HDL cholesterol levels.
    Itskowitz MS
    N Engl J Med; 2006 Jan; 354(4):417-9; author reply 417-9. PubMed ID: 16436777
    [No Abstract]   [Full Text] [Related]  

  • 39. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles.
    Ståhlman M; Fagerberg B; Adiels M; Ekroos K; Chapman JM; Kontush A; Borén J
    Biochim Biophys Acta; 2013 Nov; 1831(11):1609-17. PubMed ID: 23896361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.